Validation of a novel digitized trail making test - Year two

Age-based diseases of cognitive dysfunction such as dementia and Alzheimer’s are a growing problem in Canada that already cost the healthcare system over $10 billion annually. The ability to provide the general public with ubiquitous access to iterative cognitive function testing would be extremely valuable to the individual, society, and science. LRDG has commenced development of a digital cognitive test to achieve this goal. However, before the test can be commercialized, its function must be verified, and test outcomes must be validated.

Validation of a novel digitized trail making test

Age-based diseases of cognitive dysfunction such as dementia and Alzheimer’s are a growing problem in Canada that already cost the healthcare system over $10 billion annually. The ability to provide the general public with ubiquitous access to iterative cognitive function testing would be extremely valuable to the individual, society, and science. LRDG has commenced development of a digital cognitive test to achieve this goal. However, before the test can be commercialized, its function must be verified, and test outcomes must be validated.